Qualigen Therapeutics appoints Robert B. Lim as Audit Committee Chair

AIxCrypto Holdings, Inc.

Robert B. Lim appointed Chair of Audit Committee effective June 20, 2025, replacing Graydon Bensler.
Bensler remains on the Board and as a member of the Audit Committee.
Lim is qualified as independent under Nasdaq rules and as an audit committee financial expert.
No material interest or arrangement exists in connection with Lim's appointment.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.